pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
THERAPEUTIC AREA
save

Ophthalmology

Diseases of the eye and visual system.

also known as: eye, vision, ocular

🐶 often sniffed alongside

top 8
  • tagApproval176 co-mentions · 88 sources
  • tagRecall128 co-mentions · 36 sources
  • drugapraclonidine hydrochloride88 co-mentions · 44 sources
  • tagAdCom60 co-mentions · 53 sources
  • drugFlarex56 co-mentions · 28 sources
  • company$CAHCARDINAL HEALTH INC38 co-mentions · 5 sources
  • tag510(k) Clearance31 co-mentions · 26 sources
  • tagPMA Approval29 co-mentions · 27 sources
drugs
368
catalysts
16
news
1,133
companies
258

Top drugs

view all →
Marketed
Restasis
Keratoconjunctivitis Sicca (Dry Eye)
$ABBV · 123 catalysts
Marketed
adalimumab
Intermediate Uveitis
$ABBV · 61 catalysts
Marketed
DOXYCYCLINE HYCLATE
$AMRX · 49 catalysts
Marketed
methylprednisolone sodium succinate
Drug Hypersensitivity Reactions
48 catalysts
Marketed
METHYLPREDNISOLONE ACETATE
Giant Cell Arteritis (Temporal Arteritis/Cranial Arteriti…
41 catalysts
Marketed
prednisolone acetate
Anterior Segment Inflammation
$ABBV · 37 catalysts
Marketed
MEDROL
$PFE · 34 catalysts
Marketed
MINOCYCLINE HYDROCHLORIDE
Actinomycosis
34 catalysts

🐶 Top companies

view all →
  • $BLCOBausch & Lomb Corp
    12 products
  • $GKOSGLAUKOS Corp
    8 products
  • $ABBVAbbVie Inc.
    7 products
  • F. Hoffmann-La Roche Ltd
    6 products
  • $IRDOpus Genetics, Inc.
    6 products
  • $ALCALCON INC
    5 products
  • Cloudbreak Therapeutics LLC
    5 products
  • $HROWHARROW, INC.
    5 products

Recent catalysts

view all →
Apr 30, 2026
phase 2 completion
7mo ago
Shenzhen Eye Hospital — umbilical cord mesenchymal stem cells derived apoptotic vesicles (Phase II Trial Completion)
umbilical cord mesenchymal stem cells derived apoptotic vesicles
→
Apr 30, 2026
phase 1 2 completion
7mo ago
Eyebiotech Ltd — MK-8748 (Phase I/II Trial Completion)
MK-8748
→
Apr 30, 2026
phase 1 completion
7mo ago
Ilife Consulting Sarl — PST-611 (Phase I Trial Completion)
PST-611
→
Apr 30, 2026
filing
7mo ago
Xbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))
ranibizumab biosimilar
→
Apr 30, 2026
filing
7mo ago
Xbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))
ranibizumab biosimilar
→
Apr 30, 2026
filing
7mo ago
Xbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))
ranibizumab biosimilar
→
Apr 30, 2026
filing
7mo ago
Xbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))
ranibizumab biosimilar
→
Apr 30, 2026
filing
7mo ago
Xbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))
ranibizumab biosimilar
→
Apr 29, 2026
phase 3 initiation
7mo ago
All India Institute of Medical Sciences Bathinda — mitomycin (Phase III Trial Initiation)
Jelmyto
→
Apr 29, 2026
phase 2 completion
7mo ago
Massachusetts Eye and Ear Infirmary — N-acetylcysteine (Phase II Trial Completion)
N-acetylcysteine
→

Recent news

view all →
  • STAT+: 7 burning questions about the FDA’s post-Overton future↗
    stat · 6h ago
  • FDA Approves First Drug to Treat Neurological Symptoms of Type 3 Gaucher Disease↗
    fda press · 7h ago
  • GSK nabs FDA greenlight for second lung cancer asset from Nuvalent buy↗
    biospace · 13h ago
  • Pfizer enters in vivo CAR-T space via 3-program, $2.6B deal with China’s Starna↗
    fiercebiotech · 17h ago
  • At Fierce’s London event, Big Pharmas tell biotechs to ‘be transparent’ to secure deals↗
    fiercebiotech · 23h ago
  • FDA Launches the Global Reliance Disclosure Program to Expand Patient Access to Medicines Worldwide↗
    fda press · 1d ago
  • J&J bets $2.2B on Ollin’s vision loss drug↗
    biopharma dive · 2d ago
  • ALDI Recalls Priano Protein Carbonara Tortelloni and Priano Protein Herb & Cheese Tortelloni Because Of Possible Health Risk↗
    fda recalls · 2d ago
Data sources
openFDA · ClinicalTrials.gov · pharmadog Linker
last refreshed 2m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?